conflict
-
3-FDA staff note financial ties in Zimmer spine study
WASHINGTON, Nov 2 (Reuters) – U.S. reviewers have raised the possibility of bias in the evaluation of a spine device…
Read More »
By Emily Rappleye The Boston Globe’s Spotlight Team recently reported on an ongoing controversy at Boston-based Massachusetts General Hospital — one…
Read More »WASHINGTON, Nov 2 (Reuters) – U.S. reviewers have raised the possibility of bias in the evaluation of a spine device…
Read More »